Stem Cell Research (Oct 2021)

Generation of a laminopathies-specific iPSC line EHTJUi005-A-3 with homozygous knockout of the LMNA gene by CRISPR/Cas9 technology

  • Ji-Zhen Lu,
  • Zhi-Bin Qiao,
  • Lu Zhang,
  • Hong-Xia Cao,
  • Zhi-Hui Bai,
  • Yi-Yao Qi,
  • Han-Yu Zhu,
  • Ya-Qi Chen,
  • Shou-Mei Zhang,
  • Xiu-Hua Yan,
  • Yan Bao,
  • Wen-Wen Jia,
  • Zhong-Min Liu

Journal volume & issue
Vol. 56
p. 102530

Abstract

Read online

LAMIN A/C, encoded by the LMNA gene, supports the normal structure of the cell nucleus and regulates the connection between the nucleus and the cytoskeleton as a component of the nucleus envelope. The loss of expression and function of the LMNA gene would lead to the occurrence of congenital muscular dystrophy and Emery-Dreifuss muscular dystrophy which are collectively named as laminopathies. Here, we report a human induced pluripotent stem cell (iPSC) line (EHTJUi005-A-3) generated from a wild iPSC (EHTJUi005-A) with homozygous knockout of the gene LMNA through CRISPR/Cas9. This iPSC line provides a useful research model for studying laminopathies disease.